{"id":55808,"date":"2026-01-29T20:52:09","date_gmt":"2026-01-29T12:52:09","guid":{"rendered":"https:\/\/flcube.com\/?p=55808"},"modified":"2026-01-29T20:52:10","modified_gmt":"2026-01-29T12:52:10","slug":"organon-completes-465m-jada-system-sale-to-laborie-medical","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=55808","title":{"rendered":"Organon Completes $465M JADA System Sale to Laborie Medical"},"content":{"rendered":"\n<p><strong>Organon<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/OGN:NYSE\">NYSE:\u202fOGN<\/a>) announced the completed acquisition of its <strong>JADA system<\/strong> by <strong>Laborie Medical Technologies Corp.<\/strong> for <strong>$465\u202fmillion<\/strong> . The transaction, initially struck in <strong>November\u202f2024<\/strong>, transfers ownership of the postpartum hemorrhage treatment device, marking Organon\u2019s latest portfolio optimization move.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-structure-amp-deal-terms\">Transaction Structure &amp; Deal Terms<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Seller<\/strong><\/td><td>Organon &amp; Co. (NYSE:\u202fOGN)<\/td><\/tr><tr><td><strong>Buyer<\/strong><\/td><td>Laborie Medical Technologies Corp.<\/td><\/tr><tr><td><strong>Asset<\/strong><\/td><td>JADA system<\/td><\/tr><tr><td><strong>Deal Value<\/strong><\/td><td>USD\u202f465\u202fmillion<\/td><\/tr><tr><td><strong>Agreement Date<\/strong><\/td><td>November\u202f2024<\/td><\/tr><tr><td><strong>Closing Date<\/strong><\/td><td>January\u202f2026<\/td><\/tr><tr><td><strong>Strategic Rationale<\/strong><\/td><td>Portfolio optimization; focus on core women&#8217;s health and biosimilars<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-product-profile-amp-market-position\">Product Profile &amp; Market Position<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Product<\/strong><\/td><td>JADA system<\/td><\/tr><tr><td><strong>Indication<\/strong><\/td><td>Control and treatment of abnormal postpartum uterine bleeding\/postpartum hemorrhage requiring conservative management<\/td><\/tr><tr><td><strong>Technology<\/strong><\/td><td>Device\u2011based therapy for obstetric hemorrhage<\/td><\/tr><tr><td><strong>Market Need<\/strong><\/td><td>Postpartum hemorrhage affects <strong>~14\u202fmillion women<\/strong> : globally annually; leading cause of maternal mortality in developing regions<\/td><\/tr><tr><td><strong>Competitive Landscape<\/strong><\/td><td>Competes with Bakri balloon, B\u2011Lynch sutures, and pharmacologic interventions; JADA offers minimally invasive alternative<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact-amp-strategic-implications\">Market Impact &amp; Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Organon Portfolio Focus:<\/strong> Divestiture enables Organon to concentrate resources on <strong>women\u2019s health pharmaceuticals<\/strong> and <strong>biosimilars<\/strong> while monetizing non\u2011core medical device assets<\/li>\n\n\n\n<li><strong>Laborie Expansion:<\/strong> Acquisition strengthens Laborie\u2019s <strong>urogynecology and obstetrics portfolio<\/strong>, providing entry into the <strong>$800\u202fmillion<\/strong> global postpartum hemorrhage device market<\/li>\n\n\n\n<li><strong>Revenue Impact:<\/strong> $465\u202fmillion proceeds bolster Organon\u2019s balance sheet, supporting <strong>$2\u202fbillion<\/strong> debt reduction target and potential bolt\u2011on acquisitions in core therapeutic areas<\/li>\n\n\n\n<li><strong>Device Market Growth:<\/strong> Postpartum hemorrhage management devices growing at <strong>8% CAGR<\/strong>, driven by rising cesarean rates and improved hospital protocols<\/li>\n\n\n\n<li><strong>Next Steps:<\/strong> Integration of JADA into Laborie\u2019s commercial infrastructure expected <strong>Q2\u202f2026<\/strong>; Organon to provide transition services through <strong>mid\u20112026<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding transaction proceeds deployment, market growth projections, and strategic portfolio evolution for Organon and Laborie. Actual results may differ due to integration challenges, competitive dynamics, and changes in healthcare reimbursement policies.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Organon (NYSE:\u202fOGN) announced the completed acquisition of its JADA system by Laborie Medical Technologies Corp&#8230;.<\/p>\n","protected":false},"author":1,"featured_media":55810,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4443,972,174],"class_list":["post-55808","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-laborie-medical-technologies","tag-nyse-ogn","tag-organon"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Organon Completes $465M JADA System Sale to Laborie Medical - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Organon (NYSE:\u202fOGN) announced the completed acquisition of its JADA system by Laborie Medical Technologies Corp. for $465\u202fmillion . The transaction, initially struck in November\u202f2024, transfers ownership of the postpartum hemorrhage treatment device, marking Organon\u2019s latest portfolio optimization move.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=55808\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Organon Completes $465M JADA System Sale to Laborie Medical\" \/>\n<meta property=\"og:description\" content=\"Organon (NYSE:\u202fOGN) announced the completed acquisition of its JADA system by Laborie Medical Technologies Corp. for $465\u202fmillion . The transaction, initially struck in November\u202f2024, transfers ownership of the postpartum hemorrhage treatment device, marking Organon\u2019s latest portfolio optimization move.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=55808\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-29T12:52:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-29T12:52:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2906.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55808#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55808\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Organon Completes $465M JADA System Sale to Laborie Medical\",\"datePublished\":\"2026-01-29T12:52:09+00:00\",\"dateModified\":\"2026-01-29T12:52:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55808\"},\"wordCount\":309,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55808#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2906.webp\",\"keywords\":[\"Laborie Medical Technologies\",\"NYSE: OGN\",\"Organon\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55808#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55808\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=55808\",\"name\":\"Organon Completes $465M JADA System Sale to Laborie Medical - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55808#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55808#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2906.webp\",\"datePublished\":\"2026-01-29T12:52:09+00:00\",\"dateModified\":\"2026-01-29T12:52:10+00:00\",\"description\":\"Organon (NYSE:\u202fOGN) announced the completed acquisition of its JADA system by Laborie Medical Technologies Corp. for $465\u202fmillion . The transaction, initially struck in November\u202f2024, transfers ownership of the postpartum hemorrhage treatment device, marking Organon\u2019s latest portfolio optimization move.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55808#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55808\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55808#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2906.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2906.webp\",\"width\":1080,\"height\":608,\"caption\":\"Organon Completes $465M JADA System Sale to Laborie Medical\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55808#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Organon Completes $465M JADA System Sale to Laborie Medical\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Organon Completes $465M JADA System Sale to Laborie Medical - Insight, China&#039;s Pharmaceutical Industry","description":"Organon (NYSE:\u202fOGN) announced the completed acquisition of its JADA system by Laborie Medical Technologies Corp. for $465\u202fmillion . The transaction, initially struck in November\u202f2024, transfers ownership of the postpartum hemorrhage treatment device, marking Organon\u2019s latest portfolio optimization move.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=55808","og_locale":"en_US","og_type":"article","og_title":"Organon Completes $465M JADA System Sale to Laborie Medical","og_description":"Organon (NYSE:\u202fOGN) announced the completed acquisition of its JADA system by Laborie Medical Technologies Corp. for $465\u202fmillion . The transaction, initially struck in November\u202f2024, transfers ownership of the postpartum hemorrhage treatment device, marking Organon\u2019s latest portfolio optimization move.","og_url":"https:\/\/flcube.com\/?p=55808","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-29T12:52:09+00:00","article_modified_time":"2026-01-29T12:52:10+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2906.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=55808#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=55808"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Organon Completes $465M JADA System Sale to Laborie Medical","datePublished":"2026-01-29T12:52:09+00:00","dateModified":"2026-01-29T12:52:10+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=55808"},"wordCount":309,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=55808#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2906.webp","keywords":["Laborie Medical Technologies","NYSE: OGN","Organon"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=55808#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=55808","url":"https:\/\/flcube.com\/?p=55808","name":"Organon Completes $465M JADA System Sale to Laborie Medical - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=55808#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=55808#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2906.webp","datePublished":"2026-01-29T12:52:09+00:00","dateModified":"2026-01-29T12:52:10+00:00","description":"Organon (NYSE:\u202fOGN) announced the completed acquisition of its JADA system by Laborie Medical Technologies Corp. for $465\u202fmillion . The transaction, initially struck in November\u202f2024, transfers ownership of the postpartum hemorrhage treatment device, marking Organon\u2019s latest portfolio optimization move.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=55808#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=55808"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=55808#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2906.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2906.webp","width":1080,"height":608,"caption":"Organon Completes $465M JADA System Sale to Laborie Medical"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=55808#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Organon Completes $465M JADA System Sale to Laborie Medical"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2906.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55808","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=55808"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55808\/revisions"}],"predecessor-version":[{"id":55811,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55808\/revisions\/55811"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/55810"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=55808"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=55808"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=55808"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}